Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
250 participants
OBSERVATIONAL
2024-08-19
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to understand how health information can be accurately collected from the medical records of individuals who have received the Galleri test in a real world setting. The collected information may include relevant medical and cancer history, diagnostic test results, including the Galleri test result. This will help GRAIL build a future larger study for individuals who have taken the Galleri test. This future study is important for understanding patient journeys after a Galleri test (including any diagnostic testing done and any diagnoses made), for improving the Galleri test, and to contribute to other research on cancer screening.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Galleri® in the Medicare Population.
NCT05673018
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
NCT06523868
REFLECTION: A Clinical Practice Learning Program for Galleri®
NCT05205967
The Circulating Cell-free Genome Atlas Study
NCT02889978
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
NCT03085888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of giving signed and legally effective informed consent. Consent provided by a legally authorized representative is not permitted in this protocol.
* Have signed HIPAA authorization(s)\* form for their medical records to be released and used for this study.
Exclusion Criteria
* Patients who have received the Galleri test in a GRAIL-sponsored research setting (i.e., clinical trial) are excluded.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GRAIL, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mai Tran, MPA
Role: PRINCIPAL_INVESTIGATOR
GRAIL, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GRAIL
Menlo Park, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRAIL-MA-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.